TNFSF10 and neoplasm: AZD6244 treatment of severe combined immunodeficiency (SCID) mice, bearing s.c. Me13 xenografts, exerted a moderate but significant tumor inhibition effect, while TRAIL had no impact on tumor growth (Figure 6a).